Navigation Links
Peer Reviewed Journal Article Indicates Repros' Proellex Exhibits,Potential for New Approach to the Treatment and Prevention of,Breast Cancer

in the development of pharmaceutical products that address conditions of the male and female reproductive systems. Proellex, the Company's lead compound, a PRM (progesterone receptor modulator) has recently completed a successful U.S. three-month Phase 2 clinical trial for the treatment of uterine fibroids, a condition that affects numerous women of childbearing age in the United States and results in a significant number of hysterectomies each year. Proellex has recently completed a six-month European Phase 1/2 study for the treatment of endometriosis, a condition that affects approximately 5.5 million women in the United States and Canada. Androxal(TM), the Company's other program in late clinical development, is designed to restore normal testosterone production by the testes and has recently completed a six-month U.S. non-pivotal Phase 3 clinical trial for the treatment of testosterone deficiency in men due to secondary hypogonadism. According to industry sources, approximately 13 million men in the United States experience testosterone deficiency. The Company is planning meetings with the FDA for all three programs to lay out the remaining clinical program pathway required before a New Drug Application may be submitted for each product candidate.

For more information, please visit the Company's website at http://www.reprosrx.com.

Any statements that are not historical facts contained in this release are forward-looking statements that involve risks and uncertainties, including Repros' ability to have success in the clinical development of its technologies, the timing of enrollment in such clinical studies and the accuracy of such studies, Repros' ability to raise additional capital on acceptable terms or at all, and such other risks which are identified in the Company's Annual Report on Form 10-K for the year ended December 31, 2006, and Repros' Quarterly Report on Form 10-Q for the quarter ended March 31, 2007, as they may be updated by the Comp
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Medicures MEND-CABG Trial Results Published in Peer Reviewed Journal
2. CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively Licensed to Subsidiary, RXi Pharmaceuticals, Described in Peer-Reviewed Journal
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
5. New Study in Journal of Pediatrics Suggests Synagis (Palivizumab) May Reduce Subsequent Recurrent Wheezing in Preterm Infants
6. Genetics Journal Thimerosal/Autism Study the Best Science Drug Company Money Can Buy
7. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
8. Research on New Treatment for Neglected Disease Published in The New England Journal of Medicine
9. Nuvelo Announces Publication of Phase 2 rNAPc2 Study Results in Journal of American College of Cardiology
10. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
11. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
Post Your Comments:
(Date:8/21/2014)... -- Vermillion, Inc. (NASDAQ: VRML ), a multivariate ... has appointed Holly B. Bauzon as Vice ... Bauzon has a proven track record in both increasing ... companies. She has more than 20 years of healthcare ... the position of Director, Lab Services Sales and Managed ...
(Date:8/21/2014)...  eRelevance Corporation ( www.erelevancecorp.com ), a progressive ... has completed integration with Nextech, a popular Electronic ... Dermatology practices. "Integration allows our service ... using Nextech," stated Bob Fabbio , co-founder ... the EMR we are able to automatically target ...
(Date:8/21/2014)... NEW YORK , Aug. 21, 2014  Publicis ... Shannon Hartley , Managing Partner and Healthcare Industry ... of PharmaVoice 100, which recognizes the most inspiring people ... group are leaders in research and development, marketing, technology, ... the agency in 2006 as a partner in its ...
Breaking Medicine Technology:Vermillion Appoints Holly B. Bauzon as VP of Sales and Managed Markets 2eRelevance Corporation Integrates with Nextech Electronic Medical Records 2Shannon Hartley Shines in PharmaVOICE 100 2
... The AXA Research Fund closed out its first year ... than Euro 13 million to various European research institutions.The purpose ... of major risks in the world by supporting cutting edge ... Euro 100 million over five years, making it a major ...
... Research features from Mayo ClinicROCHESTER, Minn., March 23 ... of Discovery,s Edge, Mayo Clinic,s research magazine. You ... often as you wish. Reprinting is allowed with ... as your editorial policies permit: Visit http://discoverysedge.mayo.edu ...
Cached Medicine Technology:First Year Results of the AXA Research Fund: Over Euro 13 Million Allocated for Research in 2008 2First Year Results of the AXA Research Fund: Over Euro 13 Million Allocated for Research in 2008 3Discovery's Edge Spring Issue - http://discoverysedge.mayo.edu 2
(Date:8/22/2014)... August 22, 2014 FastFingerprints is adding ... The office will open Wednesday, August 27, 2014 and ... OH 44115. With the addition of this new ... FastFingerprints locations in the Cleveland area. Our new ... FBI background checks. The hours of operation will be ...
(Date:8/22/2014)... The rising numbers of teen drug and teen ... For many years, countless lives have been lost due to ... community a new helpline was established to provide a valuable ... who are seeking to overcome their addiction issues. , ... parents and their teens can speak immediately to a representative ...
(Date:8/22/2014)... 2014 Teen substance abuse has long ... Unfortunately, most young adults never receive the professional treatment ... community, the new Troubled Teens Columbus helpline was established ... overcome their drug and alcohol dependencies . ... and their parents can speak directly to a representative ...
(Date:8/22/2014)... 22, 2014 Drug and alcohol ... the years, substance abuse has claimed thousands of lives ... OH is providing hope for teenagers who are seeking ... helpline is designed to provide adolescents and their parents ... find the best youth rehab facility to meet their ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Dr Murray Grossan ... this snoring cure. , In the October 2014 issue of ... Dr Grossan about his method of treating snoring, and in ... Dr Grossan: "Nearly half of all adults snore occasionally, and ... This is because air passages in the back of the ...
Breaking Medicine News(10 mins):Health News:FastFingerprints Expands In The Cleveland Ohio Area 2Health News:FastFingerprints Expands In The Cleveland Ohio Area 3Health News:Troubled Teens in Asheville, NC Turn to Helpline for Valuable Assistance 2Health News:New Helpline in Columbus Assists Troubled Teen Find Youth Rehab 2Health News:Substance Abuse Helpline Provides Hope for Teens & Parents in Brunswick, OH 2Health News:Dr Murray Grossan Explains how and why Singing Exercises Stop Snoring 2Health News:Dr Murray Grossan Explains how and why Singing Exercises Stop Snoring 3
... studies find no clear link; other research supports fiber to ... -- An adult woman,s intake of meat, eggs and dairy ... research shows. , For years, dietary factors have been debated ... with research yielding conflicting results. But in the new research, ...
... , DETROIT, Aug. 28 WDIV-TV, ... launch The Biggest Loser: Detroit Edition contest on Monday, August 31. ... applicants to compete in this 12-week weight loss challenge to be ... is one of the most popular programs, and America,s Thanksgiving Parade ...
... absentee rate, research shows , FRIDAY, Aug. 28 (HealthDay ... work, employees take more sick days, a new study ... nearly 3,000 workers and found that absenteeism was higher ... interfering with work. These employees felt the demands they ...
... NEW YORK, Aug. 28 A serious breathing condition ... and helping to manage it could mean paying special attention ... Listen to this report from Boehringer Ingelheim Pharmaceuticals, Inc. & ... , Registered journalists can access video, audio, text, ...
... , , , , ... Inc. (NYSE: DVA ), a leading provider of kidney ... announced its nocturnal dialysis patient population has reached a milestone, with ... DaVita(R) centers around the nation. DaVita has one of the largest ...
... after, and protect liver from damage, experts say , FRIDAY, ... lots of water, get plenty of rest -- and eat ... the amino acids and minerals in asparagus extract may ease ... , Researchers at the Institute of Medical Science and Jeju ...
Cached Medicine News:Health News:Meat, Dairy Won't Up Odds for Breast Cancer 2Health News:Meat, Dairy Won't Up Odds for Breast Cancer 3Health News:WDIV-TV, Blue Cross Blue Shield of Michigan and The Parade Company Help Launch The Biggest Loser: Detroit Edition 2Health News:DaVita Offers Dialysis While Patients Sleep 2Health News:DaVita Offers Dialysis While Patients Sleep 3Health News:Asparagus May Ease Hangover 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: